Association between hsCRP≥2, Coronary Artery Calcium, and Cardiovascular Events – Implications for the JUPITER Population: Multi-Ethnic Study of Atherosclerosis (MESA)

BACKGROUND: The JUPITER trial demonstrated that some patients with LDL-C <130 mg/dL and hsCRP ≥2 mg/L benefit from rosuvastatin, although absolute event rates were low. We sought to determine whether coronary artery calcium (CAC) may further risk stratify a JUPITER-eligible population, and to com...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Blaha, Michael J., Budoff, Matthew J., DeFilippis, Andrew P., Blankstein, Ron, Rivera, Juan J., Agatston, Arthur, O’Leary, Daniel H., Lima, Joao, Blumenthal, Roger S., Nasir, Khurram
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3173039/
https://ncbi.nlm.nih.gov/pubmed/21856482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(11)60784-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak